Genetic Testing in Male Infertility
Genetic testing is most useful in selected men with azoospermia, very severe oligozoospermia or clinical findings suggesting a genetic cause. It is not a routine panel for every mildly abnormal semen report. The main tests are a karyotype for chromosome abnormalities, Y-chromosome microdeletion testing for severe spermatogenic failure, and CFTR testing when congenital absence of the vas deferens is suspected. Results can explain the cause, predict whether sperm retrieval is worthwhile, identify health issues such as Klinefelter syndrome and show whether an abnormality could be passed to children.
Why genetics matters in male infertility
As sperm production becomes more severely impaired, chromosomal and Y-chromosome abnormalities become more common. A genetic diagnosis can prevent futile surgery, guide micro-TESE counselling, trigger appropriate partner testing and help the couple understand reproductive risks before IVF/ICSI.
Main genetic tests
| Test | Typical indication / information |
|---|---|
| Karyotype | Azoospermia or severe oligozoospermia with impaired sperm production; detects extra/missing chromosomes and major structural rearrangements |
| Y-chromosome microdeletion | NOA or very severe oligozoospermia; AZFa/AZFb/AZFc result has important sperm-retrieval and inheritance implications |
| CFTR testing | Congenital bilateral or unilateral absence of vas deferens and selected obstructive azoospermia |
| Targeted/specialist gene panels | Selected syndromic or unexplained severe infertility; use is expanding but should be guided by phenotype and counselling rather than ordered indiscriminately |
Karyotype: what can it find?
A karyotype examines chromosome number and large structural rearrangements. Klinefelter syndrome (47,XXY) is a well-known finding in azoospermic men. Balanced translocations or inversions may not cause obvious health symptoms in the man but can increase the risk of miscarriage or unbalanced chromosomes in embryos, so genetic counselling becomes part of fertility planning.
Y-chromosome microdeletion: why it is different
This test examines the AZF regions involved in spermatogenesis. Complete AZFa or AZFb deletions carry essentially no chance of sperm retrieval and are a reason not to perform TESE. AZFc deletion has a variable phenotype; testicular sperm can be found in many men, but any son conceived from that sperm will inherit the deletion.
CFTR testing and absent vas deferens
Congenital bilateral absence of the vas deferens is often associated with CFTR variants. If the male carries a pathogenic variant, the female partner may need CFTR testing so the couple can understand the risk of cystic fibrosis or related disease in a child. The male may also need evaluation for renal or other congenital anomalies depending on the anatomy and genetic findings.
Does every man with low sperm count need genetics?
No. The yield rises as sperm concentration falls and when there is evidence of impaired production. EAU guidance strongly recommends Y-microdeletion testing at sperm concentrations of 1 million/mL or less and considers it below 5 million/mL; karyotype thresholds vary between guidelines but are generally aimed at azoospermia and severe oligozoospermia rather than mild isolated low count.
What happens after an abnormal result?
- Genetic counselling to explain the finding and inheritance.
- Modification of the sperm-retrieval plan when the genotype predicts poor or absent retrieval.
- Discussion of IVF/ICSI and, in selected chromosome abnormalities, embryo or prenatal genetic testing.
- Health evaluation beyond fertility when the syndrome has endocrine, metabolic or other implications.
- Testing of the female partner in CFTR-related obstruction or other couple-specific situations.
What genetic testing cannot do
A normal karyotype and Y-microdeletion result do not prove that sperm production is normal and do not identify every possible genetic cause. Many men with severe infertility remain without a single molecular diagnosis. Results should therefore be used as one layer of the clinical evaluation rather than a complete explanation of fertility potential.
What each genetic test actually answers
Genetic tests are targeted to the clinical pattern. A karyotype looks for chromosome-number or structural abnormalities such as Klinefelter syndrome. Y-chromosome microdeletion testing looks for missing regions important for sperm production. CFTR testing is particularly relevant when the vas deferens is congenitally absent or another CFTR-related obstruction is suspected.
The result can influence the chance of finding sperm, whether a male child could inherit the problem, whether the female partner needs carrier testing and whether genetic counselling should occur before IVF/ICSI.
Emergency warning signs
A genetic-test result is not an emergency. Urgent care is reserved for separate acute symptoms such as sudden severe testicular pain, marked swelling, fever/redness or major trauma; genetic counselling and fertility planning can then proceed in a structured way.
What to bring for consultation
Bring these if available:
- Semen analyses showing the severity of oligozoospermia/azoospermia.
- FSH, LH and testosterone.
- Physical exam/scrotal ultrasound findings if available.
- Family history of infertility, miscarriages, congenital disorders or cystic fibrosis.
- Any previous genetic report.
- Partner’s carrier-screening/genetic reports if relevant.
FAQs
Who should get a Y-chromosome microdeletion test?
It is particularly indicated in azoospermia and very severe oligozoospermia due to impaired sperm production. EAU recommends testing at ≤1 million sperm/mL and considering it below 5 million/mL.
What is the common chromosome problem in azoospermic men?
Klinefelter syndrome, usually 47,XXY, is the most common sex-chromosome abnormality associated with severe spermatogenic failure.
Can a genetic problem be passed to a child through ICSI?
Some can. For example, an AZFc Y-chromosome deletion will be transmitted to male offspring. Other chromosome abnormalities may increase miscarriage or embryo aneuploidy risk.
Does a normal genetic report mean micro-TESE will succeed?
No. It removes some known genetic explanations but does not guarantee focal sperm production.
Is CFTR testing needed in non-obstructive azoospermia?
Not routinely. It is mainly relevant when congenital absence of the vas deferens or a CFTR-related obstructive pattern is suspected.
Related reading
- Y-Chromosome Microdeletion Test
- Klinefelter Syndrome and Infertility
- Azoospermia: No Sperm in Semen
- Obstructive Azoospermia
- Non-Obstructive Azoospermia
- Urologist in Latur
References
- European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Male Infertility. 2026 https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility
- American Urological Association/American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; Amended 2024) https://www.auanet.org/documents/Guidelines/PDF/2024%20Guidelines/Male%20Infertility%20Unabridged%20Final.pdf